Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1850 of 1863 entries
View as:

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00398073 Org: User:
Start: 10/31/06 End: 03/31/11 Due: 03/31/12

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00260026 Org: User:
Start: 11/30/04 End: 01/31/07 Due: 01/31/08

Assessment of Comskil Training Through Videorecording and Patient Surveys

Phase: N/A Priority: Normal
NCT ID: NCT00943813 Org: User:
Start: 05/31/09 End: 08/31/16 Due: 08/31/17

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00588185 Org: User:
Start: 02/28/03 End: 02/28/26 Due: 02/28/27

Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01622660 Org: User:
Start: 06/30/12 End: 02/29/16 Due: 02/28/17

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01908777 Org: User:
Start: 07/16/13 End: 07/31/25 Due: 07/31/26

Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02269293 Org: User:
Start: 10/13/14 End: 04/20/21 Due: 04/20/22

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT02639767 Org: User:
Start: 12/31/15 End: - Due: -

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01866293 Org: User:
Start: 05/28/13 End: 08/18/16 Due: 08/18/17

Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)

Phase: N/A Priority: Normal
NCT ID: NCT03851458 Org: User:
Start: 05/05/15 End: 05/31/26 Due: 05/31/27

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

Phase: N/A Priority: Normal
NCT ID: NCT04419519 Org: User:
Start: 05/13/20 End: 05/31/26 Due: 05/31/27

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00082836 Org: User:
Start: 12/31/04 End: - Due: -

Genetic Susceptibility to Lung Cancer in Never Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00597636 Org: User:
Start: 06/30/05 End: 06/30/26 Due: 06/30/27

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006019 Org: User:
Start: 05/31/00 End: 08/31/03 Due: 08/31/04

ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

Phase: N/A Priority: Normal
NCT ID: NCT02106507 Org: User:
Start: 04/30/14 End: 06/28/21 Due: 06/28/22

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05990478 Org: User:
Start: 08/03/23 End: 07/26/24 Due: 07/26/25

Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03168971 Org: User:
Start: 01/23/19 End: 01/21/26 Due: 01/21/27

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02252887 Org: User:
Start: 01/12/15 End: 09/30/26 Due: 09/30/27

A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06243757 Org: User:
Start: 01/08/24 End: 01/08/36 Due: 01/08/37

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05927610 Org: User:
Start: 06/19/23 End: 02/15/24 Due: 02/15/25

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05215353 Org: User:
Start: 01/14/22 End: 01/31/26 Due: 01/31/27

Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00582296 Org: User:
Start: 12/31/04 End: 12/31/25 Due: 12/31/26

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People with Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05141643 Org: User:
Start: 11/18/21 End: 11/18/25 Due: 11/18/26

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT00589784 Org: User:
Start: 10/31/07 End: 10/31/14 Due: 10/31/15

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02111681 Org: User:
Start: 04/30/14 End: 07/01/24 Due: 07/01/25